Skip to content

To evaluate the Safety and efficacy of Unani formulations in the treatment of Headache

Clinical Validation of Unani Pharmacopoeial Formulation â?? Arq Ajeeb for symptomatic releif in SudÄ?â?? (Headache)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/03/005608
Enrollment
540
Registered
2015-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache Health Condition 2: null- Headache (SudÄ?)

Interventions

Intervention1: Arq Ajeeb: Local application, Q.S, Twice daily,Apply locally on the forehead for seven days Control Intervention1: nil: na

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of either sex with age 18-65 years • Patients having SudÄ?â?? (Headache) with or without any of the following symptoms: ï?§ Disturbed concentration ï?§ Irritability ï?§ Zuâ??f al-IshtihÄ?â?? (Decreased appetite) ï?§ Iâ??yÄ? (Fatigue) ï?§ Difficulty in falling asleep and staying asleep ï?§ Mild sensitivity to light/ noise

Exclusion criteria

Exclusion criteria: • Headache does not respond to standard therapy • Headache accompanied by impaired neurological functions (loss of balance, weakness, numbness, or speech disturbances), double vision, seizures, mental disturbances, and loss of consciousness. • Headache accompanied by persistent nausea, vomiting, fever and stiff neck • History of recent head injury. • Known cases of any other acute illness. • Known cases of severe Renal/ Hepatic/ Cardiac ailments • Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in signs and symptoms of SudÄ?â?? (Headache)Timepoint: 7 days

Secondary

MeasureTime frame
Haematological and biochemical assessment for safetyTimepoint: 7 days

Countries

India

Contacts

Public ContactDR PRADEEP KUMAR

Central Council for Research in Unani Medicine (CCRUM),

ccrum507@gmail.com9810161758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026